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SQA ABSTRACTS - Angiography & Interventional Cardiology 
Conclusions: In ISR lesions, LSM lends to occur more often with BT than without BT. The 
mechanism is usually an increase in EEM (positive remodeling) greater than the increase 
in plaque. 
Baseline (mm2) Follow-up(mm2) P 
Mean EEM 20.464.62 
Mean Intra-stent lumen 6.96k1.46 
Mean Stent 6.69t1.69 
Mean Plaque 11.75*3.79 
Mean Effective Lumen 6.96k1.46 
Control segment 
23.05*5.19 0.004 
7.42*2.1.92 0.326 
6.77e1.63 0.424 
12.63i4.26 0.11 
9.07r2.04 0.062 
Mean EEM 19.92*4.34 20.95*5.06 0.246 
Mean Lumen 7.05tl.54 6.4&i .15 0.091 
Mean Stem 6.49e1.67 6.26e1.55 0.424 
Mean Plaque 11.43zt2.97 12.66 23.96 0.155 
1128-186 Two-Year Clinical Follow-Up of lntracoronary Radiation 
Therapy Using 188Re-DTPA-Filled Balloon System After 
Coronary Artery Stenting 
Youna-Seek Cho, Bon-Kwon Koo, In-Ho Chae, Myoung-Mook Lee, Young-Bae Park, 
Seoul National University, Seoul, South Korea 
Background: Intra-coronary beta radiation therapies are known to reduce restenosis rate 
after coronary angioplasty, but late effects of these procedures are uncertain. The objec- 
tive of this study is to evaluate the long-term effect on clinical outcome of 166Re-DTPA- 
filled balloon system following coronary artery stenting. 
Methods: One-hundred twenty-two patients with significant de now or in-stent restenosis 
lesions were recruited in this prospective, randomized. case-controlled study and fol- 
lowed-up for 34.0 f 6.6 months. 64 patients were randomized to 166Re group and 56 to 
control group. 
Results: There were no significant differences in clinical diagnosis, cardiovascular risk 
factors, and angiographic lesion characteristics between two groups. At two-year clinical 
follow-up, target-vessel revascularization rate (TVR) was significantly lower in 166Re 
group (14.1% vsrsus 29.3%: P = 0.040) than control group, maintaining early benefit 
observed at 6-months (10.9% in 166Re group versus 27.6% in control; P = 0.019). Two 
patients in 166Re group (at 16-months and 24-months follow-up, respectively) and one in 
control group (at 34 months) received a new TVR after 6.months follow-up. There were 
one non-fatal myocardial infarction in 166Re group at 19.months, and no cardiac death 
after 6-months. The composite end point of cardiac death, non-fatal MI, or TVR at two- 
years follow-up period did not show significant difference between both groups (15.6% in 
166Re versw 29.3% in control; P = 0.069), although it had been significantly lower in 
166Re group by 6-months (29.3% versus 12.5%; P = 0.022). 
Conclusion: Long-term outcomes of intracoronary radiation therapy with 166Re-DTPA- 
filled balloon after coronary artery stenting were favorable with a low rate of NR, 
although some late failures were observed. 
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1129-173 Low Stroke Rates During Carotid Artery Stenting With 
Neuroprotection 
Gishel New, Gary S. Roubin, Sriram S. lyer, Roxana Mehran. Yuliya G. Adamyan. 
Christina Brennan, George Dangas, Monica Losquadro, Michael Guiry, Palawi Kumar. 
Jiri J. Vitek. Lenox Hill Heart and Vascular Institute. Cardiovascular Research 
Foundation, New York, NY 
Background: Neuroprotection devices are used during carotid stenting to eliminate dis- 
tal embolic debris and subsequent neurologic complications. 
Methods: We report results after carotid artery stenting using a variety of distal protec- 
tion devices in 376 patients (397arteries) [(MednovaTM, n=69, AngioguardTM, n=6, Accu- 
netTM, n=4) a distal balloon occlusion catheter (PercusurgeGuardwireTM, 11~266) or a 
proximal balloon occlusion catheter (ParodiTM. n=lO)]. Devices were chosen on the basis 
of intracranial collateral circulation, “high-risk” features and eligibility criteria for specific 
protocols. All patients had a NIH Stroke Scale performed before and within 24 hours after 
the procedure. 
Results: The mean age was 73 f 10 years. 14% had a history of stroke, amaurosis 
fugax in 6% and 30%, had a history of TIA within the past B-months, 13% had a prior 
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CEA. 11% had prior neck radiation or surgery, 46% had bilateral disease and 9% had a 
contralateral occlusion. Procedural success @tent placement and no complication) was 
achieved in 96.7%. 
Thirty-Day Outcomes All pts Balloon Filter P-Value 
N= patients/arteries 378/397 2791296 99/101 NS 
Minor Stroke 4 (1.2%) 3 (1.0%) 1 (1.0%) NS 
Major Stroke 1 (0.3%) 1 (0.3%) 0 NS 
Retinal Embolus 4(1.0%) 3(1.0%) l(l.O%) NS 
Stroke Related Death 1(0.3%) 1 (0.3%) 0 NS 
Non-Stroke Related Death 2 (0.6%) 2 (0.6%) 0 NS 
All Strokes and Deaths 8 (2.2%) 7 (2.3%) 1 (1.0%) NS 
All Strokes 6 (1.5%) 5 (1.7%) 1 (1.0%) NS 
There were no differences in outcomes between filters or balloon occlusion devices. The 
only multivariate predictor of stroke was a contralateral occlusion. 
Conclusion: Neuroprotection during carotid stenting is associated with low neurologic 
complication of any type (embolic or other) without any differnce between balloon occlu- 
sion or filters. These data support the use of these devices in all carotid stsnting proce- 
dures. 
1129-174 The Volume of Embolic Particles Retrieved via Distal 
Protection Is Similar With Either Occlusion Balloon or 
Filter, but Markedly Lower in Carotid Arterial Than 
Saphenous Vein Grafl Interventions 
Arun Kuchsla Andrew C. Eisenhauer, Rany Huynh. Bernard Chevalier, Joachim 
Schafer, Philip A. Seifelt, Natalie D. Macon, Campbell Rogers, Brigham B Women’s 
Hospital, Boston, MA, Massachusetts Institute of Technology, Cambridge, MA 
Objective: Characterize particulate retrieved from carotid artery interventions (CAI) and 
aorto-coronary saphenous vein graft interventions (SVGI) either via a distal occlusion 
balloon or an embolic protection filter. 
MethodeiResults: Particulate from 3 CAI and 17 SVGI using embolic occlusion balloon 
protection (Percusurge, Medtronic/AVE) and 5 CAI and 47 SVGI using a braided nitinol 
filter (Medtronic AVE) was analyzed for particle size and aggregate embolic volume 
using an automated computer imaging system (Rapidwe, Beckman Couiter). The parti- 
cle size distribution for all groups was nearly identical, with the majority being < 96 pm in 
longest dimension (Figure). The embolic volumes for CAI (2.79 mm3 for balloon, 2.72 
mm3 for filter) were significantly smaller than for SVGI. using either a balloon or filter (16 
mm3 for both). Histologic evaluation revealed similar composition. 
Conclusion: Aggregate embolic volumes for similar interventions are equivalent regard- 
less of whether balloon occlusion or filter protection is employed. However, CAI yield only 
approximately 20% of the embolic volume of SVGI, with similar size distributions. Either 
SVG lesions provide a larger embolic load, or carotid lesions are prone to incomplete 
capture due to loss up the external carotid artery. 
1129-175 Carotid Artery Stenting Can Be Safely Performed in 
Elderly Patients: A Single Center Experience 
John P. Reilly, Hugo Quintana, Tyrone J. Collins, James S. Jenkins, Stephen R. Ramee, 
Christopher J. White, Ochsner Clinic, New Orleans, LA 
Background: Carotid artery stenting (CAS) is an accepted treatment for carotid artery 
disease, and is particularly attractive in patients at high risk for surgical endarterectomy. 
Previous reports suggest that elderly patients are at high risk for significant complications 
during CAS. 
Methods: A prospective database of all patients undergoing CAS at our institution was 
interrogated. All patients over 60 years old were evaluated. We reviewed hospital and 
outpatient records of all patients to confirm and complete the database. The primary end- 
points evaluated were neurologic events during the hospitalization and at 30 days. 
Results: Glpatients over 80 years old underwent 65 CAS procedures at our institution 
since July 1994. The mean age was 62.62 2.6 years (range 60 - 95 years). 32 CAS pro- 
cedures were performed on the right carotid ariery and 33 on the left carotid artery. The 
mean stenosis was 90.6% -+ 6.9%. There were 15 diabetics, 12 smokers, 39 hyperten- 
sives and 33 with hypercholesterolemia. Eighteen patients had previously undergone 
coronary bypass surgery, and nine had previously undergone carotid endalterectomy. 
Ten patients had a prior myocardial infarction. Twenty-five patients were asymptomatic. 
In-hospital event rates for 61 CAS procedures (93.6%) were obtained. and follow-up at 
30 days was available for 39 CAS procedures (60.0%). Two patients (3.6%) had events 
during the initial hospitalization, which were classified as minor strokes by a neurologist. 
